Tau imaging enables the observation of the distribution of tau in the brain of AD patients, allowing to predict AD symptom progression by comparing data on the correlation between the temporal-spatial distribution of pathological tau and the pathology of AD. Here, MAPT is linked to Alzheimer disease.